Fundraising Fox
Concarlo
Brooklyn, US · Founded 2015 · 4 known investors
Find your way into Concarlo
Sign up to see every warm intro you have to Concarlo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Concarlo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers. It focuses on precision oncology, advancing a lead compound through preclinical development.
Founders & leadership
Concarlo was founded in 2015 by Stacy Blain.
SB
Stacy BlainFounder, CEOA cancer biologist who spent two decades as an associate professor in the departments of cell biology and pediatrics at SUNY Downstate Medical Center, she moved her laboratory research on cell cycle regulation toward commercialization in 2016. She has taken part in the Springboard Enterprises healthtech cohort and the Creative Destruction Lab cancer stream, and is a member of Chief.
LC
LisaMarie CaseyPresident and Manager
DM
Dustin MrazExecutive Board Member / Co-founder
Board
JM
Investors · 4
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · Not right? Tell us
Catalytic Impact Foundationlisted by Catalytic Impact FoundationHingham
How we know: Catalytic Impact Foundation's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$450K disclosed across 1 round · 2017
▶$450KraisedMar 2017 · 6 investors · BiotechnologyRule 506(b)
▶$450KraisedMar 2017 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LisaMarie CaseyExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $450K
- Minimum investment
- $25K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Protara TherapeuticsProtara develops transformative therapies for patients with cancer and rare diseases, applying modern scientific and manufacturing advancements to accelerate drug development.
Capricor TherapeuticsCapricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy. The company uses cell and exosome biology platforms to create novel therapeutic medicines for patient treatment.
CertaraCertara provides biosimulation software, modeling, and regulatory services that support drug discovery and development across discovery, preclinical, clinical, regulatory, and market access phases. It serves pharmaceutical and biotech organizations seeking to make data-driven decisions and streamline regulatory submissions.
Companies working in the same space as Concarlo.
In the news
Frequently asked questions
- What does Concarlo do?
- Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers. It focuses on precision oncology, advancing a lead compound through preclinical development.
- Who founded Concarlo?
- Concarlo was founded by Stacy Blain in 2015.
- Who are Concarlo's investors?
- Concarlo's investors include BioAdvance, Catalytic Impact Foundation, Creative Destruction Lab (CDL), Raptor Group.
- How much funding has Concarlo raised?
- Concarlo has disclosed $450K raised across 1 round.
- Where is Concarlo headquartered?
- Concarlo is headquartered in Brooklyn, US.